Stifel Initiates Coverage On Whitehawk Therapeutics with Buy Rating, Announces Price Target of $9

Benzinga · 1d ago
Stifel analyst Dara Azar initiates coverage on Whitehawk Therapeutics (NASDAQ:WHWK) with a Buy rating and announces Price Target of $9.